INTRODUCTION
DNA in the double-stranded form is a rather stable structure that, however, has to become partially unwound, at least transiently, to form the single-stranded intermediate templates required to perform its most important transactions, such as replication, repair, recombination and transcription. DNA helicases are the enzymes which catalyse the unwinding of double-stranded DNA to provide single-stranded templates for such processes (1) (2) (3) . Helicases generally bind in vitro to DNA single strands and translocate unidirectionally along the DNA into a duplex region disrupting the hydrogen and other weak bonds between the two strands. These enzymes contain an intrinsic DNA-dependent ATPase activity which hydrolyses the 'y-phosphate of ATP or dATP and provides the energy for the reaction (1) (2) (3) .
Multiple DNA helicases have been isolated from both prokaryotes and eukaryotes (2, 3) . Specific functions have been identified for many of the prokaryotic, yeast and viral DNA helicases but in the case of mammalian, especially of human DNA helicases, the in vivo function is still unknown.
Our systematic study of the human DNA helicases (HDH) initiated in the past years, has led us until now to the isolation of five different DNA helicases from HeLa cell cultures, namely HDH I (4), HDH II (5) , HDH Im (6) , HDH IV (7) and HDH V (8) , and to the identification of the genes for two of them. HDH I-V appear different from the other DNA helicases reported from the same source, namely DNA helicase £ (9) and DNA helicase a (10) . Recently we have identified HDH II as Ku, an autoantigen recognized by sera of scleroderma and lupus erythematosus patients and involved in the repair of double-stranded DNA breaks as well as in the V(D)J recombination process of immunoglobulin genes (5) . We have also identified HDH IV as nucleolin, a ubiquitous eukaryotic protein essential for rRNA maturation (11) . Here we report the purification to homogeneity and the properties of another previously unidentified DNA Oligonucleotides and helicase substrate The oligodeoxynucleotides used for constructing the DNA helicase substrates were synthesized chemically by the ICGEB oligonucleotide service and purified electrophoretically. The sequences of all the DNA and RNA oligonucleotides have been previously described (4) (5) (6) (7) (8) . The structure of all the substrates (DNA-DNA, DNA-RNA and RNA-RNA) used in this study are shown in the Results section. All the DNA-DNA, DNA-RNA, RNA-RNA and directionspecific substrates were prepared as described earlier (4-7).
Helicase and DNA-dependent ATPase assay
The DNA helicase assay was performed in a 10 gl reaction volume. The reaction mixture contained 20 mM Tris-HCl (pH 8.0), 0.8 mM MgCl2, 100 mM KCI, 5 The ssDNA-dependent ATPase activity was determined in the same conditions as the helicase assay by using the method described previously (6) .
Preparation of dsDNA and ssDNA affinity column For dsDNA, first the genomic DNA from HeLa cells was isolated as described (12) (8) . DNA topoisomerases were assayed according to Kaiserman et al. (13) except that the plasmid DNA used was Bluescript containing a cDNA insert of 1 kb human cGMP phosphodiesterase (14) . DNA ligase and DNA nicking activities were checked as described earlier (4, 15) . The DNA polymerase was assayed as described by Ottiger and Hubscher (16 Table 1 whereas the elution profiles of all the chromatography steps are shown in Figure 1 . The nuclear extract preparation, ammonium sulfate precipitation and Bio-Rex 70 column chromatography using buffer A were performed as described previously (4, 6 (Fig. IC) . After washing the column with buffer B the bound proteins were eluted with a linear gradient (90 ml) from 0.1 to 1.0 M NaCl in buffer B. The activity eluted from the column at -0.45 M NaCl in buffer B (fraction IV; 37 ml, 769 600 U). Up to this step we found that DNA helicase activity and dsDNA-binding activity (data not shown) corresponding to the transcription factor USF (upstream regulatory factor) (18) were present together to get resolved only in the following column chromatography. Fraction IV was diluted with buffer C, made 3 mM in MgCl2, and loaded onto a 4 ml ssDNA-Sepharose column equilibrated with buffer C. The column was washed with buffer C and eluted with a linear gradient (80 ml) from 0.1 to 1.0 M NaCl in buffer C (Fig. ID) . The helicase activity eluted from the column at 0.45 M NaCl in buffer C (fraction V; 11 ml, 528 000 U). The dsDNA-binding activity (data not shown) did not bind to the column and eluted in the flow-through and washing fractions. Fraction V was pure to apparent homogeneity and showed one band of -128 kDa on SDS-polycrylamide gel electrophoresis as revealed by silver staining (Fig. 2A, lane 2 ) .
From 327 g of HeLa cells we were able to recover 0.44 mg of apparently pure enzyme with specific activity of 1.2 x 106 U/mg. Purified HDH VI (fraction V) was free of DNA topoisomerase, ligase, polymerase, nuclease and nicking activities.
ssDNA-dependent ATPase activity was present at a level of -102 pmol ATP hydrolysed in 30 min by 2 ng of pure HDH VI. The UV-mediated covalent labelling of the pure preparation with [a-32P]ATP showed one radioactive band of -128 kDa (Fig. 2B) .
Reaction requirements and characterisation of HDH VI
The substrate used for the characterisation of the helicase activity of HDH VI contained hanging tails at both 5' and 3' ends (Fig.  6A) . The reaction requirements are shown in Table 2 . HDH VI is heat labile and loses its activity upon heating at 56°C for 1 min. Even when stored at 4°C HDH VI loses 90% of its activity in 24 h. The enzyme activity was destroyed if trypsin was included in the reaction. The activity was totally inhibited by 200 mM KCl or NaCl, 5 mM EDTA, 45 mM ammonium sulfate, 100 mM potassium phosphate buffer (pH 8.0), M13 ssDNA (30 mM as phosphate) and histone at 1 mg/ml ( Table 2 ). The M13 replicative form I DNA, nicked M13 dsDNA, HeLa cell total RNA and Escherichia coli t-RNA at 30 mM as phosphate had no effect on helicase activity of HDH VI ( Table 2 ). The optimum concentrations of ATP, MgCl2 and KCl for helicase activity are 5, 0.8 and 100 mM, respectively (Fig. 3) . Without ATP or MgCl2 or KCl HDH VI does not show any activity (Fig. 3) . At high concentration of ATP (40 mM) or MgCl2 (4 mM) or KCl (200 mM) the activity was inhibited (Fig. 3) The kinetics of helicase reaction at optimum assay conditions with 2 ng (2.4 U) HDH VI (fraction V) shows a linear rate up to 30 min (Fig. 4A) and deviates from linearity with longer incubation. Titration of helicase activity with increasing amount of HDH VI showed a saturation beyond 2 ng (Fig. 4B) .
The native molecular weight and Stokes radius of HDH VI were determined by a combination of glycerol gradient sedimentation (Fig. 5A ) and gel filtration chromatography on Superose 12 FPLC column (Pharmacia) (Fig. SB) , as described by Siegel and Monty (19) . These results show that HDH VI has a native molecular weight of -128 kDa, with a sedimentation coefficient of 6.7 S and a Stokes radius of 44 A, corresponding to an (f:fo) ratio of 1.36.
DNA helicase activity with various substrates
The different structures of the substrates used in this study are shown in Figure 6 . Substrate (-1 ng) and 2 ng of HDH VI were used for each assay. The results show that HDH VI prefers for its unwinding action the substrates containing a replication fork-like structure (Fig. 6A, C and D) . If the same substrate does not contain hanging tails the unwinding ability is markedly reduced (but not abolished) (Fig. 6B) . If the annealed portion in the tailless substrate increases to 32 bp (Fig. 6E) , or to 41 bp in one of the tailed substrates (Fig. 6F) , HDH VI fails to unwind. It also cannot unwind blunt-ended duplex substrates of 17 bp (Fig. 6G) .
HDH VI unwinds DNA in the 3' to 5' direction Direction-specific substrates were constructed as described previously (5,7). On a small substrate the results show that HDH VI unwinds by moving along the single-stranded portion in the 3' to 5' direction ( Fig. 6H) and not in the 5' to 3' direction (Fig. 61) . The direction of unwinding was further confirmed on longer substrates (Fig. 6J and K) , with which HDH VI also shows unwinding only in the 3' to 5' direction ( Fig. 6J) and not in the 5' to 3' direction (Fig. 6K) .
DNA-RNA and RNA-RNA unwinding by HDH VI The DNA-RNA substrate consisted of a 32P-labelled 17mer RNA oligonucleotide annealed to M13 ssDNA (Fig. 6L) . The results show that HDH VI cannot unwind DNA-RNA or RNA-RNA substrates (Fig. 6L and M) . fork advancement (22) (23) (24) . The human basal transcription factor BTF2 (TFIIH) has also been shown to contain DNA helicase activity which is believed to be important in disrupting the DNA duplex at transcriptional start sites, showing a connection between transcription and a DNA helicase (25) .
In the course of our systematic survey of the DNA helicases present in human cells, that has brought to the identification and complete purification of six different such enzymes (4-8 and (26) . Also, we were able to show that human DNA helicase IV corresponds in fact to nucleolin, that is an RNA helicase involved in the maturation and transport of ribosomal RNA and modulated in its unwinding action by two different protein kinases (11) . Human DNA helicase VI, described in the present paper, appears to be a monomer of 128 kDa as determined both under native and denaturing conditions, a fact that differentiates it from calf thymus helicases A, C and D (29-31) that tend to form aggregates in low salt conditions. It unwinds DNA moving in the 3' to 5' direction on the bound strand, like all other human DNA helicases described by our group (4-6,8) (except HDH IV) as well as DNA helicase a (10) and £ (9) from HeLa cells, calf thymus helicase I and 11 (27) , SV40 T antigen (22) and Polyoma T antigen (23) ; this polarity of movement distinguishes the enzyme from calf thymus DNA helicases B, C, D, F and 6 (28) (29) (30) , and mouse helicase B (32) all of which move in the 5' to 3' direction on the bound strand. Human DNA helicase VI cannot unwind DNA/RNA or RNA/RNA substrates, similar to HDH II, III and V (5, 6, 8) as against what has been reported for calf thymus DNA helicase II (27) . The enzyme prefers a fork-like structure for its substrate, as shown also for HDH 11 (5) , HDH III (6) and calf thymus 6 helicase (28) (see Fig. 6A ), and different from calf thymus helicases B, C and F (29-30) and mouse helicase B (32) . Still, this preference is not absolute: as Figure 6B shows, significant activity is observed also with the substrate lacking a partially unwound structure. The enzyme seems also to require that at least one arm of the fork-like structure to which it binds be rather long: this is shown by the fact that the substrate shown in Figure 6H is less fit than the one of Figure 6C . This double request (preference for single-stranded portion, request for at least one arm to be very long), probably explains why the enzyme is inactive on the substrate reported in Figure 61 , while it is partially active on the one of Figure 6H . Furthermore, the high positivity of the result with the substrate shown in Figure 6 , can be explained in this context only by considering that on this molecule the enzyme can act on both sides at the same time even if at a less than optimal rate: i.e., we must consider that the molecule can at the same time, unwind the labelled oligo from the 5' end, as it does in the substrate of Figure 6B , and from the 3' partially unwound end, as it does on the molecules of Figure 6H .
The overall catalytic properties of HDH VI are very similar to those of HDH Ill (and distinct from those of all the other four helicases purified by our group); on the other hand, HDH Ill is a much smaller molecule (46 kDa in SDS-PAGE, versus 128 kDa of HDH VI) and we can rule out any possibility of the former being a precursor of the latter, since the two molecules are totally unrelated immunologically. In fact, a rabbit antiserum raised against HDH III is unable to recognise HDH VI in Western blotting (data not shown).
We are in the process of cloning the genes for this helicase as well as for helicases I, III and V; a comparison of the sequences with possible already known structures, as well as the analysis of the effect on replicative or repair processes of the inactivation of the function by microinjection in the nuclei of specific antibodies against each helicase, may offer in the future an indication on the in vivo role of these enzymes.
